Japanese distributor liable over diabetes products
The dispute concerned blood sugar monitors used by people with diabetes
A Chinese-owned developer of products for diabetes sufferers has applied to a US court to enforce a US$22.6 million ICC award against its Japanese former parent company concerning a terminated distribution deal.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Upgrade now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10